Micro
Emerging
Active
Desafios de integração impactam o desempenho da Stride no 4º trimestre.
New narrative with limited coverage — still forming.
Pontuação
0,2
Velocidade
▲ 0,0
Artigos
1
Fontes
1
Sentiment Timeline
Event Timeline
Hipóteses
Pending
Prazo: 23 de Junho de 2026
LRN's operating margin will contract by 150-250 basis points in Q4 2024 compared to Q4 2023 specifically attributable to integration costs and operational redundancies
Pending
Prazo: 23 de Julho de 2026
LRN stock price will underperform S&P 500 by 8-15% in the 60 days following Q4 earnings release due to integration-related margin compression concerns
Pending
Prazo: 23 de Junho de 2026
Stride Health (LRN) Q4 2024 revenue will decline by 5-10% year-over-year due to integration disruptions, with recovery beginning in Q1 2025
Cronologia
Primeira detecçãoMar 25, 2026
Última atualizaçãoMar 25, 2026